CTRI/2020/04/024881尚未招募未知
A randomised controlled trial to compare oral iron supplementation in once daily versus alternate day dosage to single dose parenteral iron therapy for correction of iron deficiency in subjects with stage G3-4 chronic kidney disease. - Nil
Dr Manu Dogra0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Iron deficiency defined as TSAT < 30 % and serum ferritin < 500mg/dL
- •2. Clinically stable course for last 3 months
排除标准
- •1.Blood hemoglobin < 9 g/dl
- •2.Current use or use within last 3 months of oral or intravenous iron preparations
- •3.Known / suspected diagnosis of autoimmune disease
- •4.Past or present diagnosis of malignancy
- •5.Known diagnosis of chronic liver disease
- •6.History of any bleeding diathesis
- •7.History of gastro-intestinal surgery
- •8.Present or past diagnosis of peptic ulcer disease, gastro-intestinal bleeding or any form of gastro-intestinal disease predisposing to malabsorption
- •9.Currently taking gastric acid inhibitors (H2 receptor blockers, proton pump inhibitors)
- •10.History of allergic reactions to any form of oral or intravenous iron preparations
- •11.History of prior non-compliance with oral iron therapy due to gastro-intestinal side effects
- •12.Current use or use within last 6 months of immunosuppressive drug therapy
- •13.Pregnancy or lactation, in case of females
- •14.Life expectancy < 1 year
研究者
相似试验
尚未招募
不适用
Malaria and Iron deficiency studyHaematological DisordersPaediatricsMalariaPACTR2010050002141682College of Medicine600
已完成
4 期
HEMATOCRIT Trial: A randomised controlled trial of oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets for the correction of anaemia in peritoneal dialysis patientsdarbepoetin-treated peritoneal dialysis patientsAnaemia in peritoneal dialysis patients treated with darbepoetinRenal and Urogenital - Kidney diseaseACTRN12610000678099Amgen60
招募中
3 期
A randomised controlled trial of oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)Iron deficiency anaemiaRenal and Urogenital - Kidney diseaseACTRN12609000432213Professor David Johnson60
进行中（未招募）
不适用
A clinical open, randomised study of oral iron (Duroferon®) vs. intravenous iron (Ferinject®) for iron substitution in blood donors.Iron deficiency.MedDRA version: 9.1Level: LLTClassification code 10022972Term: Iron deficiency anaemiaMedDRA version: 9.1Level: LLTClassification code 10022975Term: Iron deficiency anemia secondary to blood loss (chronic)EUCTR2009-010623-64-SERenapharma AB210
已完成
4 期
Iron Substitution After Upper Gastro-Intestinal BleedingGastrointestinal HemorrhageAnemiaNCT00978575University of Aarhus97